2009.04.27 - NVAX

Pre-Market:

NVAX - +153% pre marketben...

Novavax Says Preclinical Study Demonstrates Virus-like Particle Vaccine Provided Protection Against Pathogenic H1N1, H5N1 Influenza Strains

(RTTNews) - Novavax Says Preclinical Study Demonstrates Virus-like Particle Vaccine Provided Protection Against Pathogenic H1N1, H5N1 Influenza Strains